We has surveyed the Gene Editing Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Gene editing is a new and accurate genetic engineering technology that can modify specific target genes in the genome of an organism.
Gene editing technology refers to the ability for humans to "edit" targeted genes to achieve modifications to specific DNA fragments.
Gene editing relies on genetically engineered nucleases, also known as "molecular scissors," to produce site-specific double-strand breaks (DSBs) at specific locations in the genome, inducing organisms to connect via non-homologous end junctions (NHEJ) or homologous Source Recombination (HR) to repair DSB because this repair process is error-prone, resulting in targeted mutations
This report contains market size and forecasts of Gene Editing Technology in Global, including the following market information:
- Global Gene Editing Technology Market Size 2024-2030, ($ millions)
- The global Gene Editing Technology market is projected to reach US$ million by 2029.
Total Market by Segment:
Global Gene Editing Technology Market, by Type, 2024-2030 ($ millions)
Global Gene Editing Technology Market Segment Percentages, by Type
- Homologous Recombination
- Meganuclease
Global Gene Editing Technology Market, by Application, 2024-2030 ($ millions)
Global Gene Editing Technology Market Segment Percentages, by Application
- Agriculture
- Medical
- Other
Global Gene Editing Technology Market, By Region and Country, 2024-2030 ($ Millions)
Global Gene Editing Technology Market Segment Percentages, by region and country
- United States
- Europe
- Asia
- China
- Rest of World
- Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
- Thermo Fisher Scientific
- SIGMA ALDRICH
- Dharmacon
- Cellectics
- CRISPR Therapeutics
- AstraZeneca
- Bio Rad
- Allele Biotech
- Recombinetics
- Lonza
- GE Healthcare
- Editas Medicine
- Agilent Technologies
- QIAGEN NV
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gene Editing Technology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene Editing Technology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene Editing Technology Overall Market Size
2.1 Global Gene Editing Technology Market Size: 2023 VS 2030
2.2 Global Gene Editing Technology Market Size, Prospects & Forecasts: 2023-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key Gene Editing Technology Players in Global Market
3.2 Global Companies Gene Editing Technology Product & Technology
4 Gene Editing Technology Companies Profiles
4.1 Thermo Fisher Scientific
4.1.1 Thermo Fisher Scientific Company Summary
4.1.2 Thermo Fisher Scientific Business Overview
4.1.3 Thermo Fisher Scientific Gene Editing Technology Product Offerings & Technology
4.1.4 Thermo Fisher Scientific Gene Editing Technology R&D, and Plans
4.2 SIGMA ALDRICH
4.2.1 SIGMA ALDRICH Company Summary
4.2.2 SIGMA ALDRICH Business Overview
4.2.3 SIGMA ALDRICH Gene Editing Technology Product Offerings & Technology
4.2.4 SIGMA ALDRICH Gene Editing Technology R&D, and Plans
4.3 Dharmacon
4.3.1 Dharmacon Company Summary
4.3.2 Dharmacon Business Overview
4.3.3 Dharmacon Gene Editing Technology Product Offerings & Technology
4.3.4 Dharmacon Gene Editing Technology R&D, and Plans
4.4 Cellectics
4.4.1 Cellectics Company Summary
4.4.2 Cellectics Business Overview
4.4.3 Cellectics Gene Editing Technology Product Offerings & Technology
4.4.4 Cellectics Gene Editing Technology R&D, and Plans
4.5 CRISPR Therapeutics
4.5.1 CRISPR Therapeutics Company Summary
4.5.2 CRISPR Therapeutics Business Overview
4.5.3 CRISPR Therapeutics Gene Editing Technology Product Offerings & Technology
4.5.4 CRISPR Therapeutics Gene Editing Technology R&D, and Plans
4.6 AstraZeneca
4.6.1 AstraZeneca Company Summary
4.6.2 AstraZeneca Business Overview
4.6.3 AstraZeneca Gene Editing Technology Product Offerings & Technology
4.6.4 AstraZeneca Gene Editing Technology R&D, and Plans
4.7 Bio Rad
4.7.1 Bio Rad Company Summary
4.7.2 Bio Rad Business Overview
4.7.3 Bio Rad Gene Editing Technology Product Offerings & Technology
4.7.4 Bio Rad Gene Editing Technology R&D, and Plans
4.8 Allele Biotech
4.8.1 Allele Biotech Company Summary
4.8.2 Allele Biotech Business Overview
4.8.3 Allele Biotech Gene Editing Technology Product Offerings & Technology
4.8.4 Allele Biotech Gene Editing Technology R&D, and Plans
4.9 Recombinetics
4.9.1 Recombinetics Company Summary
4.9.2 Recombinetics Business Overview
4.9.3 Recombinetics Gene Editing Technology Product Offerings & Technology
4.9.4 Recombinetics Gene Editing Technology R&D, and Plans
4.10 Lonza
4.10.1 Lonza Company Summary
4.10.2 Lonza Business Overview
4.10.3 Lonza Gene Editing Technology Product Offerings & Technology
4.10.4 Lonza Gene Editing Technology R&D, and Plans
4.11 GE Healthcare
4.11.1 GE Healthcare Company Summary
4.11.2 GE Healthcare Business Overview
4.11.3 GE Healthcare Gene Editing Technology Product Offerings & Technology
4.11.4 GE Healthcare Gene Editing Technology R&D, and Plans
4.12 Editas Medicine
4.12.1 Editas Medicine Company Summary
4.12.2 Editas Medicine Business Overview
4.12.3 Editas Medicine Gene Editing Technology Product Offerings & Technology
4.12.4 Editas Medicine Gene Editing Technology R&D, and Plans
4.13 Agilent Technologies
4.13.1 Agilent Technologies Company Summary
4.13.2 Agilent Technologies Business Overview
4.13.3 Agilent Technologies Gene Editing Technology Product Offerings & Technology
4.13.4 Agilent Technologies Gene Editing Technology R&D, and Plans
4.14 QIAGEN NV
4.14.1 QIAGEN NV Company Summary
4.14.2 QIAGEN NV Business Overview
4.14.3 QIAGEN NV Gene Editing Technology Product Offerings & Technology
4.14.4 QIAGEN NV Gene Editing Technology R&D, and Plans
5 Sights by Region
5.1 By Region - Global Gene Editing Technology Market Size, 2024 & 2030
5.2 By Region - Global Gene Editing Technology Revenue, (2024-2030)
5.3 United States
5.3.1 Key Players of Gene Editing Technology in United States
5.3.2 United States Gene Editing Technology Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of Gene Editing Technology in Europe
5.4.2 Europe Gene Editing Technology Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of Gene Editing Technology in China
5.5.2 China Gene Editing Technology Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global Gene Editing Technology Market Size Markets, 2024 & 2030
6.2 Homologous Recombination
6.3 Meganuclease
7 Sights by Application
7.1 By Application - Global Gene Editing Technology Market Size, 2024 & 2030
7.2 Agriculture
7.3 Medical
7.4 Other
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Gene Editing Technology Market Opportunities & Trends in Global Market
Table 2. Gene Editing Technology Market Drivers in Global Market
Table 3. Gene Editing Technology Market Restraints in Global Market
Table 4. Key Players of Gene Editing Technology in Global Market
Table 5. Global Companies Gene Editing Technology Product & Technology
Table 6. Thermo Fisher Scientific Company Summary
Table 7. Thermo Fisher Scientific Gene Editing Technology Product Offerings
Table 8. SIGMA ALDRICH Company Summary
Table 9. SIGMA ALDRICH Gene Editing Technology Product Offerings
Table 10. Dharmacon Company Summary
Table 11. Dharmacon Gene Editing Technology Product Offerings
Table 12. Cellectics Company Summary
Table 13. Cellectics Gene Editing Technology Product Offerings
Table 14. CRISPR Therapeutics Company Summary
Table 15. CRISPR Therapeutics Gene Editing Technology Product Offerings
Table 16. AstraZeneca Company Summary
Table 17. AstraZeneca Gene Editing Technology Product Offerings
Table 18. Bio Rad Company Summary
Table 19. Bio Rad Gene Editing Technology Product Offerings
Table 20. Allele Biotech Company Summary
Table 21. Allele Biotech Gene Editing Technology Product Offerings
Table 22. Recombinetics Company Summary
Table 23. Recombinetics Gene Editing Technology Product Offerings
Table 24. Lonza Company Summary
Table 25. Lonza Gene Editing Technology Product Offerings
Table 26. GE Healthcare Company Summary
Table 27. GE Healthcare Gene Editing Technology Product Offerings
Table 28. Editas Medicine Company Summary
Table 29. Editas Medicine Gene Editing Technology Product Offerings
Table 30. Agilent Technologies Company Summary
Table 31. Agilent Technologies Gene Editing Technology Product Offerings
Table 32. QIAGEN NV Company Summary
Table 33. QIAGEN NV Gene Editing Technology Product Offerings
Table 34. By Region? Global Gene Editing Technology Revenue, (US$, Mn), 2024 & 2030
Table 35. By Region - Global Gene Editing Technology Revenue, (US$, Mn), 2024-2030
Table 36. By Type ? Global Gene Editing Technology Market Size, (US$, Mn), 2024 & 2030
Table 37. By Application? Global Gene Editing Technology Market Size, (US$, Mn), 2024 & 2030
List of Figures
Figure 1. Gene Editing Technology Segment by Type in 2030
Figure 2. Gene Editing Technology Segment by Application in 2030
Figure 3. Global Gene Editing Technology Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gene Editing Technology Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Gene Editing Technology Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global Gene Editing Technology Revenue Market Share, 2024-2030
Figure 8. By Type - Global Gene Editing Technology Revenue Market Share, 2024-2030
Figure 9. By Application - Global Gene Editing Technology Revenue Market Share, 2024-2030
